Publications in collaboration with researchers from Instituto de Investigación Sanitaria Biogipuzkoa (1)

2022

  1. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

    Journal of Neuroinflammation, Vol. 19, Núm. 1